Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis
Author:
Affiliation:
1. Institute of Molecular Biology and Translational Medicine, The Affiliated People's Hospital; Jiangsu University; Zhenjiang 212002 Jiangsu China
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3781/fullpdf
Reference31 articles.
1. A review of health-related quality-of-life concepts and measures for Parkinson's disease;Damiano;Qual Life Res,1999
2. Incidence and remaining lifetime risk of Parkinson disease in advanced age;Driver;Neurology,2009
3. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai;Zhang;Lancet,2005
4. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030;Dorsey;Neurology,2007
5. Calcium channel blockers. Lessons learned from MIDAS and other clinical trials;Chobanian;JAMA,1996
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Feed-forward metabotropic signaling by Cav1 Ca2+ channels supports pacemaking in pedunculopontine cholinergic neurons;Neurobiology of Disease;2023-11
2. Feed-forward metabotropic signaling by Cav1 Ca2+channels supports pacemaking in pedunculopontine cholinergic neurons;2023-08-07
3. Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study;Heliyon;2023-08
4. Upregulated DNA Damage-Linked Biomarkers in Parkinson's Disease Model Mice;ASN Neuro;2023-01
5. Shared Molecular Targets in Parkinson’s Disease and Arterial Hypertension: A Systematic Review;Biomedicines;2022-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3